HIV: Antiretroviral Therapy (ART)
HIV: Antiretroviral Therapy (ART)Skip to the navigationTopic OverviewAntiretroviral therapy (ART) is the
combination of several antiretroviral medicines used to slow the rate at which
HIV makes copies of itself (multiplies) in the body. A
combination of three or more antiretroviral medicines is more effective than
using just one medicine (monotherapy) to treat HIV. The use of
three or more antiretroviral medicines-sometimes referred to as an anti-HIV
"cocktail"-is currently the standard treatment for HIV infection. So far, this
treatment offers the best chance of preventing HIV from multiplying, which
allows your
immune system to stay healthy. The goal of
antiretroviral therapy is to reduce the amount of virus in your body (viral
load) to a level that can no longer be detected with current blood
tests. Antiretroviral medicines that are often used to treat HIV
include: - Nucleoside/nucleotide reverse transcriptase
inhibitors, also called nucleoside analogs, such as abacavir, emtricitabine,
and tenofovir. These medicines are often combined for best
results.
- Nonnucleoside reverse transcriptase inhibitors (NNRTIs),
such as efavirenz, etravirine, and nevirapine.
- Protease inhibitors
(PIs), such as atazanavir, darunavir, and ritonavir.
- Entry inhibitors, such as enfuvirtide and maraviroc.
- Integrase
inhibitors, such as dolutegravir and raltegravir.
Some medicines are available combined together in one pill.
This reduces the number of pills to be taken each day. The U.S. National Institutes of Health recommends using one of the following programs for people who begin treatment for HIV:footnote 1 - Dolutegravir + abacavir + lamivudine
- Dolutegravir + tenofovir + emtricitabine
- Elvitegravir + cobicistat + tenofovir + emtricitabine
- Raltegravir + tenofovir + emtricitabine
- Ritonavir-boosted darunavir + tenofovir + emtricitabine
Other drug combinations are approved and may be used in some cases. Also, studies have shown that if you are not infected with HIV, taking antiretroviral medicines can protect you against HIV.footnote 2, footnote 3 But to keep your risk low, you still need to use safer sex practices. ReferencesCitations- U.S. Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents (2015). Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. U.S. Department of Health and Human Services. http://aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf. Accessed May 5, 2015.
- Grant RM, et al. (2010). Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New England Journal of Medicine, 363(27): 2588-2599.
- Baeten JM, et al. (2012). Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. New England Journal of Medicine, 367(5): 399-410.
CreditsByHealthwise Staff Primary Medical ReviewerE. Gregory Thompson, MD - Internal Medicine Adam Husney, MD - Family Medicine Specialist Medical ReviewerPeter Shalit, MD, PhD - Internal Medicine Current as ofMarch 3, 2017 Current as of:
March 3, 2017 U.S. Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents (2015). Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. U.S. Department of Health and Human Services. http://aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf. Accessed May 5, 2015. Grant RM, et al. (2010). Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New England Journal of Medicine, 363(27): 2588-2599. Baeten JM, et al. (2012). Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. New England Journal of Medicine, 367(5): 399-410. Last modified on: 8 September 2017
|
|